Bausch Health Companies (BHC) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Bausch Health Companies Revenue Highlights

Latest Revenue (Y)

$8.76B

Latest Revenue (Q)

$2.51B

Main Segment (Y)

Pharmaceutical Products

Main Geography (Y)

United States and Puerto Rico

Bausch Health Companies Revenue by Period

Bausch Health Companies Revenue by Year

Date	Revenue	Change
2023-12-31	$8.76B	7.79%
2022-12-31	$8.12B	-3.68%
2021-12-31	$8.43B	5.07%
2020-12-31	$8.03B	-6.67%
2019-12-31	$8.60B	2.64%
2018-12-31	$8.38B	-3.94%
2017-12-31	$8.72B	-9.82%
2016-12-31	$9.67B	-7.86%
2015-12-31	$10.50B	27.05%
2014-12-31	$8.26B	43.22%
2013-12-31	$5.77B	62.68%
2012-12-31	$3.55B	43.97%
2011-12-31	$2.46B	108.55%
2010-12-31	$1.18B	43.98%
2009-12-31	$820.43M	8.35%
2008-12-31	$757.18M	-10.16%
2007-12-31	$842.82M	-21.27%
2006-12-31	$1.07B	14.42%
2005-12-31	$935.54M	5.53%
2004-12-31	$886.54M	7.63%
2003-12-31	$823.72M	4.53%
2002-12-31	$788.02M	35.11%
2001-12-31	$583.26M	88.65%
2000-12-31	$309.17M	75.17%
1999-12-31	$176.50M	56.47%
1998-12-31	$112.80M	36.89%
1997-12-31	$82.40M	24.10%
1996-12-31	$66.40M	222.33%
1995-12-31	$20.60M	19.08%
1994-12-31	$17.30M	55.86%
1993-12-31	$11.10M	-

Bausch Health Companies generated $8.76B in revenue during NA 2023, up 7.79% compared to the previous quarter, and up 104.50% compared to the same period a year ago.

Bausch Health Companies Revenue by Quarter

Date	Revenue	Change
2024-09-30	$2.51B	4.47%
2024-06-30	$2.40B	12.09%
2024-03-31	$2.14B	-10.99%
2023-12-31	$2.41B	7.60%
2023-09-30	$2.24B	3.28%
2023-06-30	$2.17B	11.47%
2023-03-31	$1.94B	-11.35%
2022-12-31	$2.19B	7.18%
2022-09-30	$2.05B	4.02%
2022-06-30	$1.97B	2.55%
2022-03-31	$1.92B	-12.66%
2021-12-31	$2.20B	4.03%
2021-09-30	$2.11B	0.52%
2021-06-30	$2.10B	3.60%
2021-03-31	$2.03B	-8.40%
2020-12-31	$2.21B	3.51%
2020-09-30	$2.14B	28.49%
2020-06-30	$1.66B	-17.30%
2020-03-31	$2.01B	-9.53%
2019-12-31	$2.22B	0.68%
2019-09-30	$2.21B	2.65%
2019-06-30	$2.15B	6.75%
2019-03-31	$2.02B	-4.95%
2018-12-31	$2.12B	-0.70%
2018-09-30	$2.14B	0.38%
2018-06-30	$2.13B	6.67%
2018-03-31	$2.00B	-7.77%
2017-12-31	$2.16B	-2.52%
2017-09-30	$2.22B	-0.63%
2017-06-30	$2.23B	5.88%
2017-03-31	$2.11B	-12.23%
2016-12-31	$2.40B	-3.09%
2016-09-30	$2.48B	2.45%
2016-06-30	$2.42B	2.05%
2016-03-31	$2.37B	-13.33%
2015-12-31	$2.74B	-1.81%
2015-09-30	$2.79B	1.99%
2015-06-30	$2.73B	24.72%
2015-03-31	$2.19B	-3.91%
2014-12-31	$2.28B	10.88%
2014-09-30	$2.06B	0.74%
2014-06-30	$2.04B	8.21%
2014-03-31	$1.89B	-8.60%
2013-12-31	$2.06B	33.86%
2013-09-30	$1.54B	40.70%
2013-06-30	$1.10B	2.57%
2013-03-31	$1.07B	8.32%
2012-12-31	$986.29M	11.55%
2012-09-30	$884.14M	7.81%
2012-06-30	$820.09M	-4.21%
2012-03-31	$856.10M	24.35%
2011-12-31	$688.45M	14.63%
2011-09-30	$600.58M	-1.44%
2011-06-30	$609.39M	7.85%
2011-03-31	$565.03M	9.81%
2010-12-31	$514.56M	147.07%
2010-09-30	$208.27M	-12.78%
2010-06-30	$238.77M	8.71%
2010-03-31	$219.63M	-8.89%
2009-12-31	$241.05M	13.42%
2009-09-30	$212.52M	9.81%
2009-06-30	$193.53M	11.66%
2009-03-31	$173.32M	-4.51%
2008-12-31	$181.50M	0.22%
2008-09-30	$181.09M	-2.69%
2008-06-30	$186.09M	-10.74%
2008-03-31	$208.50M	2.26%
2007-12-31	$203.90M	-

Bausch Health Companies generated $2.51B in revenue during Q3 2024, up 4.47% compared to the previous quarter, and up 115.83% compared to the same period a year ago.

Bausch Health Companies Revenue Breakdown

Bausch Health Companies Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Branded and Other Generic Products	$960.00M	-	-	-	-
Pharmaceutical Products	$3.91B	-	-	-	-
Over the Counter Products	$1.80B	-	-	-	-
Other Revenues	$94.00M	-	-	-	-
Device Products	$2.00B	-	-	-	-
Product	-	$8.05B	$8.34B	$7.92B	$8.49B
Product and Service, Other	-	$78.00M	$92.00M	$103.00M	$112.00M

Bausch Health Companies's latest annual revenue breakdown by segment (product or service), as of Dec 23: Pharmaceutical Products (44.64%), Device Products (22.80%), Over the Counter Products (20.52%), Branded and Other Generic Products (10.96%), and Other Revenues (1.07%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Over the Counter Products	$472.00M	$490.00M	$437.00M	$1.34B	$457.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Revenues	$28.00M	$23.00M	$24.00M	$69.00M	$25.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pharmaceutical Products	$1.20B	$1.08B	$935.00M	$2.91B	$999.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Device Products	$567.00M	$547.00M	$512.00M	$1.50B	$494.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Branded and Other Generic Products	$245.00M	$258.00M	$245.00M	$697.00M	$263.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	-	-	$2.15B	$1.92B	$2.17B	$2.03B	$1.95B	$1.90B	$2.17B	$2.09B	$2.08B	$2.00B	$2.19B	$2.11B	$1.64B	$1.99B	$2.20B
Product and Service, Other	-	-	-	-	-	$21.00M	$22.00M	$18.00M	$20.00M	$20.00M	$20.00M	$21.00M	$23.00M	$24.00M	$24.00M	$23.00M	$27.00M	$27.00M	$26.00M	$26.00M

Bausch Health Companies's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Pharmaceutical Products (47.73%), Device Products (22.59%), Over the Counter Products (18.80%), Branded and Other Generic Products (9.76%), and Other Revenues (1.12%).

Bausch Health Companies Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
SPAIN	$92.00M	$84.00M	$88.00M	$78.00M	$86.00M
KOREA, REPUBLIC OF	$93.00M	$77.00M	-	-	-
JAPAN	$194.00M	$200.00M	$230.00M	$226.00M	$241.00M
ITALY	$86.00M	$76.00M	$80.00M	$85.00M	-
GERMANY	$152.00M	$147.00M	$154.00M	$144.00M	$150.00M
FRANCE	$214.00M	$203.00M	$208.00M	$179.00M	$201.00M
CHINA	$441.00M	$413.00M	$490.00M	$341.00M	$368.00M
CANADA	$366.00M	$351.00M	$343.00M	$331.00M	$339.00M
United States and Puerto Rico	$5.19B	$4.84B	$4.89B	$4.79B	$5.16B
POLAND	$319.00M	$278.00M	$280.00M	$238.00M	$231.00M
Other Countries	$1.01B	$887.00M	$986.00M	$1.01B	$995.00M
MEXICO	$322.00M	$276.00M	$256.00M	$225.00M	$228.00M
EGYPT	-	-	$156.00M	$243.00M	$218.00M

Bausch Health Companies's latest annual revenue breakdown by geography, as of Dec 23: United States and Puerto Rico (61.22%), Other Countries (11.92%), CHINA (5.20%), CANADA (4.31%), MEXICO (3.80%), POLAND (3.76%), FRANCE (2.52%), JAPAN (2.29%), GERMANY (1.79%), KOREA, REPUBLIC OF (1.10%), SPAIN (1.08%), and ITALY (1.01%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
United States and Puerto Rico	$1.53B	$1.44B	$1.25B	$1.46B	$1.36B	$1.27B	$1.11B	$1.31B	$1.22B	$1.19B	$1.11B	$1.26B	$1.25B	$1.22B	$1.16B	$1.27B	$1.30B	$1.01B	$1.21B	$1.31B
CANADA	$104.00M	$99.00M	$90.00M	$98.00M	$92.00M	$92.00M	$84.00M	$93.00M	$92.00M	$88.00M	$78.00M	$96.00M	$84.00M	$87.00M	$76.00M	$87.00M	$87.00M	$67.00M	$90.00M	$87.00M
CHINA	$132.00M	$122.00M	$97.00M	$126.00M	$113.00M	$114.00M	$88.00M	$120.00M	$116.00M	$74.00M	$103.00M	$141.00M	$120.00M	$119.00M	$110.00M	$110.00M	$94.00M	$79.00M	$58.00M	$92.00M
FRANCE	$52.00M	$65.00M	$61.00M	$45.00M	$49.00M	$63.00M	$57.00M	$44.00M	$44.00M	$58.00M	$57.00M	$48.00M	$50.00M	$56.00M	$54.00M	$48.00M	$42.00M	$42.00M	$47.00M	$45.00M
GERMANY	$40.00M	$41.00M	$44.00M	$33.00M	$34.00M	$42.00M	$43.00M	$35.00M	$55.00M	$35.00M	$45.00M	$38.00M	$36.00M	$28.00M	$42.00M	$36.00M	$32.00M	$32.00M	$44.00M	$31.00M
ITALY	$23.00M	$24.00M	$24.00M	$22.00M	$20.00M	$23.00M	$21.00M	$16.00M	$17.00M	$23.00M	$20.00M	$20.00M	$23.00M	-	-	-	-	-	-	-
JAPAN	$46.00M	$47.00M	$43.00M	$49.00M	$47.00M	$48.00M	$50.00M	$52.00M	$47.00M	$50.00M	$51.00M	$58.00M	$57.00M	$55.00M	$60.00M	$67.00M	$57.00M	$48.00M	$54.00M	$60.00M
KOREA, REPUBLIC OF	$38.00M	$34.00M	$30.00M	$24.00M	$24.00M	$23.00M	$22.00M	$19.00M	$19.00M	$20.00M	$19.00M	$20.00M	$20.00M	$16.00M	-	-	-	-	-	-
MEXICO	$88.00M	$84.00M	$76.00M	$88.00M	$90.00M	$75.00M	$69.00M	$76.00M	$70.00M	$69.00M	$61.00M	$65.00M	$66.00M	$56.00M	$69.00M	$68.00M	$68.00M	$48.00M	$41.00M	$70.00M
Other Countries	$263.00M	$272.00M	$256.00M	$279.00M	$242.00M	$252.00M	$238.00M	$240.00M	$221.00M	$207.00M	$219.00M	$220.00M	$264.00M	$241.00M	$250.00M	$289.00M	$267.00M	$204.00M	$239.00M	$257.00M
POLAND	$92.00M	$78.00M	$86.00M	$87.00M	$82.00M	$75.00M	$75.00M	$74.00M	$65.00M	$63.00M	$76.00M	$77.00M	$70.00M	$71.00M	$62.00M	$70.00M	$57.00M	$37.00M	$73.00M	$75.00M
SPAIN	$21.00M	$27.00M	$23.00M	$25.00M	$20.00M	$25.00M	$22.00M	$23.00M	$17.00M	$23.00M	$21.00M	$26.00M	$20.00M	$23.00M	$25.00M	$21.00M	$20.00M	$24.00M	-	-
EGYPT	-	-	-	-	-	-	-	-	-	-	-	$2.00M	$20.00M	$68.00M	$66.00M	$68.00M	$59.00M	$58.00M	$58.00M	$61.00M

Bausch Health Companies's latest quarterly revenue breakdown by geography, as of Sep 24: United States and Puerto Rico (63.06%), Other Countries (10.81%), CHINA (5.42%), CANADA (4.27%), POLAND (3.78%), MEXICO (3.62%), FRANCE (2.14%), JAPAN (1.89%), GERMANY (1.64%), KOREA, REPUBLIC OF (1.56%), ITALY (0.94%), and SPAIN (0.86%).

Bausch Health Companies Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TAK	Takeda Pharmaceutical	$4.26T	$1.05T
TEVA	Teva Pharmaceutical Industries	$15.85B	$4.33B
VTRS	Viatris	$15.43B	$3.74B
HLN	Haleon	$11.30B	$2.92B
BHC	Bausch Health Companies	$8.76B	$2.51B
ZTS	Zoetis	$8.54B	$2.39B
NBIX	Neurocrine Biosciences	$1.89B	$622.10M
EBS	Emergent BioSolutions	$1.05B	$254.70M
TLRY	Tilray Brands	$788.94M	$200.04M
LFCR	Lifecore Biomedical	$128.26M	$32.56M
SHPH	Shuttle Pharmaceuticals	-	-

BHC Revenue FAQ

What is Bausch Health Companies’s yearly revenue?

Bausch Health Companies's yearly revenue for 2023 was $8.76B, representing an increase of 7.79% compared to 2022. The company's yearly revenue for 2022 was $8.12B, representing a decrease of -3.68% compared to 2021. BHC's yearly revenue for 2021 was $8.43B, representing an increase of 5.07% compared to 2020.

What is Bausch Health Companies’s quarterly revenue?

Bausch Health Companies's quarterly revenue for Q3 2024 was $2.51B, a 4.47% increase from the previous quarter (Q2 2024), and a 12.15% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.4B, a 12.09% increase from the previous quarter (Q1 2024), and a 10.87% increase year-over-year (Q2 2023). BHC's quarterly revenue for Q1 2024 was $2.14B, a -10.99% decrease from the previous quarter (Q4 2023), and a 10.26% increase year-over-year (Q1 2023).

What is Bausch Health Companies’s revenue growth rate?

Bausch Health Companies's revenue growth rate for the last 3 years (2021-2023) was 3.83%, and for the last 5 years (2019-2023) was 1.81%.

What are Bausch Health Companies’s revenue streams?

Bausch Health Companies's revenue streams in c 23 are Branded and Other Generic Products, Pharmaceutical Products, Over the Counter Products, Other Revenues, and Device Products. Branded and Other Generic Products generated $960M in revenue, accounting 10.96% of the company's total revenue Pharmaceutical Products generated $3.91B in revenue, accounting 44.64% of the company's total revenue Over the Counter Products generated $1.8B in revenue, accounting 20.52% of the company's total revenue Other Revenues generated $94M in revenue, accounting 1.07% of the company's total revenue Device Products generated $2B in revenue, accounting 22.80% of the company's total revenue

What is Bausch Health Companies’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Bausch Health Companies was Pharmaceutical Products. This segment made a revenue of $3.91B, representing 44.64% of the company's total revenue.